Selection of a hepatitis B virus strain resistant to adefovir in a liver transplantation patient
Top Cited Papers
- 1 December 2003
- journal article
- case report
- Published by Elsevier in Journal of Hepatology
- Vol. 39 (6) , 1085-1089
- https://doi.org/10.1016/j.jhep.2003.09.022
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Prevalence and Clinical Correlates of YMDD Variants during Lamivudine Therapy for Patients with Chronic Hepatitis BClinical Infectious Diseases, 2003
- Histological outcome during long-term lamivudine therapyGastroenterology, 2003
- A Preliminary Benefit-Risk Assessment of Lamivudine for the Treatment of Chronic Hepatitis B Virus InfectionDrug Safety, 2002
- Extended Lamivudine Treatment in Patients With Chronic Hepatitis B Enhances Hepatitis B E Antigen Seroconversion Rates: Results After 3 Years of TherapyHepatology, 2001
- Effects of extended lamivudine therapy in Asian patients with chronic hepatitis BGastroenterology, 2000
- Lamivudine as Initial Treatment for Chronic Hepatitis B in the United StatesNew England Journal of Medicine, 1999
- A One-Year Trial of Lamivudine for Chronic Hepatitis BNew England Journal of Medicine, 1998
- Identification and characterization of mutations in hepatitis B virus resistant to lamivudineHepatology, 1998
- Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantationThe Lancet, 1997
- Selection of Mutations in the Hepatitis B Virus Polymerase During Therapy of Transplant Recipients With LamivudineHepatology, 1996